Valproic Acid Induced Fetal Malformations Are Reduced by Maternal Immune Stimulation with Granulocyte-Macrophage Colony-Stimulating Factor or Interferon γ

Por Hrubec, Terry C., Yan, Mingjin, Ye, Keying, Salafia, Carolyn M., Holladay, Steven D.
Publicado em 2006

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

Por Huhn, Gregory D., Tebas, Pablo, Gallant, Joel, Wilkin, Timothy, Cheng, Andrew, Yan, Mingjin, Zhong, Lijie, Callebaut, Christian, Custodio, Joseph M., Fordyce, Marshall W., Das, Moupali, McCallister, Scott
Publicado no J Acquir Immune Defic Syndr (2017)

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

Por Raffi, François, Orkin, Chloe, Clarke, Amanda, Slama, Laurence, Gallant, Joel, Daar, Eric, Henry, Keith, Santana-Bagur, Jorge, Stein, David K., Bellos, Nicholaos, Scarsella, Anthony, Yan, Mingjin, Abram, Michael E., Cheng, Andrew, Rhee, Martin S.
Publicado no J Acquir Immune Defic Syndr (2017)